Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
Masiá M, Fernández-González M, Padilla S, Ortega P, García JA, Agulló V, García-Abellán J, Telenti G, Guillén L, Gutiérrez F. Masiá M, et al. Among authors: guillen l. EBioMedicine. 2020 Oct;60:102999. doi: 10.1016/j.ebiom.2020.102999. Epub 2020 Sep 16. EBioMedicine. 2020. PMID: 32950003 Free PMC article.
Dyspnea and pleuritic chest pain during the COVID-19 pandemic.
Guillén L, Telenti G, Botella Á, Masiá M. Guillén L, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jan;39(1):41-42. doi: 10.1016/j.eimc.2020.06.009. Epub 2020 Jul 4. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 32693947 Free PMC article. No abstract available.
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
Padilla S, Telenti G, Guillén L, García JA, García-Abellán J, Ding C, Mora A, García-Pachón E, Gutiérrez F, Masiá M; COVID19-Elx Group. Padilla S, et al. Among authors: guillen l. Int J Antimicrob Agents. 2020 Oct;56(4):106142. doi: 10.1016/j.ijantimicag.2020.106142. Epub 2020 Aug 24. Int J Antimicrob Agents. 2020. PMID: 32853675 Free PMC article.
Preemptive interleukin-6 blockade in patients with COVID-19.
Guillén L, Padilla S, Fernández M, Agulló V, García JA, Telenti G, García-Abellán J, Botella Á, Gutiérrez F, Masiá M. Guillén L, et al. Sci Rep. 2020 Oct 8;10(1):16826. doi: 10.1038/s41598-020-74001-3. Sci Rep. 2020. PMID: 33033405 Free PMC article.
COVID-19-associated encephalitis successfully treated with combination therapy.
Freire-Álvarez E, Guillén L, Lambert K, Baidez A, García-Quesada M, Andreo M, Alom J, Masiá M, Gutiérrez F. Freire-Álvarez E, et al. Among authors: guillen l. Clin Infect Pract. 2020 Oct;7:100053. doi: 10.1016/j.clinpr.2020.100053. Epub 2020 Nov 1. Clin Infect Pract. 2020. PMID: 33163956 Free PMC article.
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.
Masiá M, Telenti G, Fernández M, García JA, Agulló V, Padilla S, García-Abellán J, Guillén L, Mascarell P, Asenjo JC, Gutiérrez F. Masiá M, et al. Among authors: guillen l. Open Forum Infect Dis. 2021 Jan 5;8(2):ofab005. doi: 10.1093/ofid/ofab005. eCollection 2021 Feb. Open Forum Infect Dis. 2021. PMID: 33614814 Free PMC article.
Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19.
Masiá M, Padilla S, García JA, García-Abellán J, Navarro A, Guillén L, Telenti G, Mascarell P, Botella Á, Gutiérrez F. Masiá M, et al. Among authors: guillen l. Front Med (Lausanne). 2021 Nov 8;8:749657. doi: 10.3389/fmed.2021.749657. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34820393 Free PMC article.
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M, Padilla S, Estañ G, Portu J, Silva A, Rivero A, González-Cordón A, García-Fraile L, Martínez O, Bernal E, Galera C, Boix Martínez V, Macias J, Montero M, García-Rosado D, Vivancos-Gallego MJ, Llenas-García J, Torralba M, García JA, Agulló V, Fernández-González M, Gutiérrez F, Martínez E; IMPAC-NEO Study Group. Masiá M, et al. Trials. 2021 Nov 27;22(1):851. doi: 10.1186/s13063-021-05777-6. Trials. 2021. PMID: 34838115 Free PMC article. Clinical Trial.
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
81 results